Cargando…
Turning cold tumors into hot tumors by improving T-cell infiltration
Immunotherapy, represented by immune checkpoint inhibitors (ICIs), has greatly improved the clinical efficacy of malignant tumor therapy. ICI-mediated antitumor responses depend on the infiltration of T cells capable of recognizing and killing tumor cells. ICIs are not effective in "cold tumors...
Autores principales: | Liu, Yuan-Tong, Sun, Zhi-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039952/ https://www.ncbi.nlm.nih.gov/pubmed/33859752 http://dx.doi.org/10.7150/thno.58390 |
Ejemplares similares
-
Turning ‘Cold’ tumors ‘Hot’: immunotherapies in sarcoma
por: Rytlewski, Jeff, et al.
Publicado: (2021) -
Nanoparticle-Based Therapies for Turning Cold Tumors Hot: How to Treat an Immunosuppressive Tumor Microenvironment
por: Giustarini, Giulio, et al.
Publicado: (2021) -
Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
por: Karin, Nathan
Publicado: (2021) -
Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors
por: Kang, Byeong Hoon, et al.
Publicado: (2022) -
Oncolytic Adenoviruses: The Cold War against Cancer Finally Turns Hot
por: Oronsky, Bryan, et al.
Publicado: (2022)